US Stock MarketDetailed Quotes

XERS Xeris Pharmaceuticals

Watchlist
  • 2.050
  • +0.070+3.54%
Close May 20 16:00 ET
  • 2.050
  • 0.0000.00%
Pre 05:30 ET
303.92MMarket Cap-4361P/E (TTM)

Xeris Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
22.33%-20.3M
54.30%-47.02M
146.35%7.47M
17.71%-14.61M
33.31%-13.74M
46.00%-26.14M
-7.70%-102.89M
44.31%-16.12M
21.48%-17.75M
-2.93%-20.61M
Net income from continuing operations
-12.75%-18.98M
34.23%-62.26M
-3.56%-13.39M
44.17%-12.19M
24.22%-19.84M
50.07%-16.83M
22.87%-94.66M
74.54%-12.93M
16.06%-21.83M
4.83%-26.19M
Operating gains losses
----
1,148.84%3.16M
114.29%2K
1,283.70%3.14M
----
----
-142.88%-301K
-101.77%-14K
380.25%227K
-6,260.00%-616K
Depreciation and amortization
1.04%3.21M
3.88%13.16M
-6.97%3.26M
9.31%3.36M
9.83%3.36M
4.91%3.18M
574.19%12.67M
289.66%3.5M
850.77%3.07M
856.88%3.06M
Deferred tax
--307K
12.29%-1.25M
----
----
----
--0
---1.42M
----
----
----
Other non cash items
-244.51%-2.79M
-182.46%-3M
68.28%-1.6M
-212.81%-361K
-104.17%-222K
-126.72%-811K
277.94%3.63M
-2,257.26%-5.05M
36.17%320K
2,109.54%5.33M
Change In working capital
59.35%-5.63M
82.09%-6.29M
692.72%17.83M
-328.23%-10.71M
108.20%445K
42.77%-13.86M
-396.52%-35.15M
-117.58%-3.01M
-206.12%-2.5M
-226.66%-5.43M
-Change in receivables
6,043.33%1.78M
37.44%-8.37M
304.38%6.77M
-793.36%-15.74M
126.76%635K
99.49%-30K
-114.43%-13.37M
-837.64%-3.31M
-39.18%-1.76M
29.31%-2.37M
-Change in inventory
38.90%-2.33M
-98.31%-14.8M
74.55%-1.4M
-30.09%-2.15M
-4,922.30%-7.43M
-2,331.21%-3.82M
-0.63%-7.47M
-142.08%-5.51M
-31.56%-1.66M
63.37%-148K
-Change in prepaid assets
-51.67%-1.86M
182.48%3.21M
280.34%2.04M
118.67%343K
337.78%2.05M
-2,012.07%-1.23M
-218.15%-3.89M
-130.71%-1.13M
-38.33%-1.84M
-190.18%-863K
-Change in payables and accrued expense
25.32%-5.18M
146.21%6.44M
701.88%6.39M
90.79%4.02M
186.42%2.97M
39.85%-6.94M
-162.46%-13.93M
-106.78%-1.06M
-33.27%2.11M
-170.47%-3.43M
-Change in other current liabilities
118.93%762K
113.24%818K
199.33%893K
--684K
--3.27M
23.75%-4.03M
---6.18M
---899K
--0
--0
-Change in other working capital
-45.18%1.2M
-33.70%6.42M
-64.72%3.14M
230.60%2.14M
-174.95%-1.04M
273.71%2.18M
12,671.43%9.68M
2,265.21%8.9M
634.71%647K
-37.40%1.39M
Cash from discontinued investing activities
Operating cash flow
22.33%-20.3M
54.30%-47.02M
146.35%7.47M
17.71%-14.61M
33.31%-13.74M
46.00%-26.14M
-7.70%-102.89M
44.31%-16.12M
21.48%-17.75M
-2.93%-20.61M
Investing cash flow
Cash flow from continuing investing activities
55.32%-19.65M
-117.42%-6M
62.17%14.87M
118.44%14.66M
-28.78%8.45M
-754.84%-43.98M
-64.82%34.46M
-74.95%9.17M
-63.74%6.71M
-28.32%11.87M
Capital expenditure reported
31.09%-164K
-331.87%-2.26M
0.00%-132K
-96.02%-345K
-567.24%-1.55M
-1,587.50%-238K
51.71%-524K
-0.76%-132K
42.67%-176K
-6.42%-232K
Net business purchase and sale
----
--0
----
----
----
----
--0
----
----
----
Net investment purchase and sale
55.45%-19.49M
-110.69%-3.74M
61.29%15M
117.86%15M
-17.36%10M
-752.85%-43.74M
-42.25%34.99M
635.71%9.3M
-63.40%6.89M
-27.86%12.1M
Cash from discontinued investing activities
Investing cash flow
55.32%-19.65M
-117.42%-6M
62.17%14.87M
118.44%14.66M
-28.78%8.45M
-754.84%-43.98M
-64.82%34.46M
-74.95%9.17M
-63.74%6.71M
-28.32%11.87M
Financing cash flow
Cash flow from continuing financing activities
4,178.10%35.19M
-101.27%-1.61M
-102.51%-1.23M
61.50%-72K
79.35%556K
-101.10%-863K
367.84%127.47M
39,224.80%49.16M
-18,800.00%-187K
-32.61%310K
Net issuance payments of debt
--38.17M
--0
--0
--0
--0
--0
--102.72M
--48.92M
--0
--0
Net common stock issuance
-297.91%-3.43M
-103.42%-1.01M
-133.33%-49K
-157.14%-72K
-733.33%-25K
-102.92%-863K
11.58%29.53M
87.57%-21K
---28K
---3K
Proceeds from stock option exercised by employees
--459K
-30.50%581K
--0
--0
13.92%581K
--0
0.12%836K
8.16%318K
--0
-0.78%510K
Net other financing activities
----
78.89%-1.19M
----
----
----
----
-10,294.44%-5.61M
---60K
---159K
---197K
Cash from discontinued financing activities
Financing cash flow
4,178.10%35.19M
-101.27%-1.61M
-102.51%-1.23M
61.50%-72K
79.35%556K
-101.10%-863K
367.84%127.47M
39,224.80%49.16M
-18,800.00%-187K
-32.61%310K
Net cash flow
Beginning cash position
-43.26%71.67M
87.77%126.31M
-39.88%50.57M
-46.93%50.6M
-46.68%55.33M
87.77%126.31M
78.92%67.27M
41.38%84.11M
49.91%95.34M
55.80%103.77M
Current changes in cash
93.30%-4.76M
-192.54%-54.64M
-49.99%21.11M
99.76%-27K
43.83%-4.74M
-294.47%-70.98M
98.96%59.04M
442.41%42.21M
-173.62%-11.23M
-180.47%-8.43M
Effect of exchange rate changes
----
--0
----
----
----
----
--0
----
----
--0
End cash Position
20.93%66.92M
-43.26%71.67M
-43.26%71.67M
-39.88%50.57M
-46.93%50.6M
-46.68%55.33M
87.77%126.31M
87.77%126.31M
41.38%84.11M
49.91%95.34M
Free cash flow
22.41%-20.47M
52.34%-49.29M
145.16%7.34M
16.59%-14.96M
26.57%-15.29M
45.51%-26.38M
-7.03%-103.42M
44.11%-16.25M
21.76%-17.93M
-2.89%-20.83M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 22.33%-20.3M54.30%-47.02M146.35%7.47M17.71%-14.61M33.31%-13.74M46.00%-26.14M-7.70%-102.89M44.31%-16.12M21.48%-17.75M-2.93%-20.61M
Net income from continuing operations -12.75%-18.98M34.23%-62.26M-3.56%-13.39M44.17%-12.19M24.22%-19.84M50.07%-16.83M22.87%-94.66M74.54%-12.93M16.06%-21.83M4.83%-26.19M
Operating gains losses ----1,148.84%3.16M114.29%2K1,283.70%3.14M---------142.88%-301K-101.77%-14K380.25%227K-6,260.00%-616K
Depreciation and amortization 1.04%3.21M3.88%13.16M-6.97%3.26M9.31%3.36M9.83%3.36M4.91%3.18M574.19%12.67M289.66%3.5M850.77%3.07M856.88%3.06M
Deferred tax --307K12.29%-1.25M--------------0---1.42M------------
Other non cash items -244.51%-2.79M-182.46%-3M68.28%-1.6M-212.81%-361K-104.17%-222K-126.72%-811K277.94%3.63M-2,257.26%-5.05M36.17%320K2,109.54%5.33M
Change In working capital 59.35%-5.63M82.09%-6.29M692.72%17.83M-328.23%-10.71M108.20%445K42.77%-13.86M-396.52%-35.15M-117.58%-3.01M-206.12%-2.5M-226.66%-5.43M
-Change in receivables 6,043.33%1.78M37.44%-8.37M304.38%6.77M-793.36%-15.74M126.76%635K99.49%-30K-114.43%-13.37M-837.64%-3.31M-39.18%-1.76M29.31%-2.37M
-Change in inventory 38.90%-2.33M-98.31%-14.8M74.55%-1.4M-30.09%-2.15M-4,922.30%-7.43M-2,331.21%-3.82M-0.63%-7.47M-142.08%-5.51M-31.56%-1.66M63.37%-148K
-Change in prepaid assets -51.67%-1.86M182.48%3.21M280.34%2.04M118.67%343K337.78%2.05M-2,012.07%-1.23M-218.15%-3.89M-130.71%-1.13M-38.33%-1.84M-190.18%-863K
-Change in payables and accrued expense 25.32%-5.18M146.21%6.44M701.88%6.39M90.79%4.02M186.42%2.97M39.85%-6.94M-162.46%-13.93M-106.78%-1.06M-33.27%2.11M-170.47%-3.43M
-Change in other current liabilities 118.93%762K113.24%818K199.33%893K--684K--3.27M23.75%-4.03M---6.18M---899K--0--0
-Change in other working capital -45.18%1.2M-33.70%6.42M-64.72%3.14M230.60%2.14M-174.95%-1.04M273.71%2.18M12,671.43%9.68M2,265.21%8.9M634.71%647K-37.40%1.39M
Cash from discontinued investing activities
Operating cash flow 22.33%-20.3M54.30%-47.02M146.35%7.47M17.71%-14.61M33.31%-13.74M46.00%-26.14M-7.70%-102.89M44.31%-16.12M21.48%-17.75M-2.93%-20.61M
Investing cash flow
Cash flow from continuing investing activities 55.32%-19.65M-117.42%-6M62.17%14.87M118.44%14.66M-28.78%8.45M-754.84%-43.98M-64.82%34.46M-74.95%9.17M-63.74%6.71M-28.32%11.87M
Capital expenditure reported 31.09%-164K-331.87%-2.26M0.00%-132K-96.02%-345K-567.24%-1.55M-1,587.50%-238K51.71%-524K-0.76%-132K42.67%-176K-6.42%-232K
Net business purchase and sale ------0------------------0------------
Net investment purchase and sale 55.45%-19.49M-110.69%-3.74M61.29%15M117.86%15M-17.36%10M-752.85%-43.74M-42.25%34.99M635.71%9.3M-63.40%6.89M-27.86%12.1M
Cash from discontinued investing activities
Investing cash flow 55.32%-19.65M-117.42%-6M62.17%14.87M118.44%14.66M-28.78%8.45M-754.84%-43.98M-64.82%34.46M-74.95%9.17M-63.74%6.71M-28.32%11.87M
Financing cash flow
Cash flow from continuing financing activities 4,178.10%35.19M-101.27%-1.61M-102.51%-1.23M61.50%-72K79.35%556K-101.10%-863K367.84%127.47M39,224.80%49.16M-18,800.00%-187K-32.61%310K
Net issuance payments of debt --38.17M--0--0--0--0--0--102.72M--48.92M--0--0
Net common stock issuance -297.91%-3.43M-103.42%-1.01M-133.33%-49K-157.14%-72K-733.33%-25K-102.92%-863K11.58%29.53M87.57%-21K---28K---3K
Proceeds from stock option exercised by employees --459K-30.50%581K--0--013.92%581K--00.12%836K8.16%318K--0-0.78%510K
Net other financing activities ----78.89%-1.19M-----------------10,294.44%-5.61M---60K---159K---197K
Cash from discontinued financing activities
Financing cash flow 4,178.10%35.19M-101.27%-1.61M-102.51%-1.23M61.50%-72K79.35%556K-101.10%-863K367.84%127.47M39,224.80%49.16M-18,800.00%-187K-32.61%310K
Net cash flow
Beginning cash position -43.26%71.67M87.77%126.31M-39.88%50.57M-46.93%50.6M-46.68%55.33M87.77%126.31M78.92%67.27M41.38%84.11M49.91%95.34M55.80%103.77M
Current changes in cash 93.30%-4.76M-192.54%-54.64M-49.99%21.11M99.76%-27K43.83%-4.74M-294.47%-70.98M98.96%59.04M442.41%42.21M-173.62%-11.23M-180.47%-8.43M
Effect of exchange rate changes ------0------------------0----------0
End cash Position 20.93%66.92M-43.26%71.67M-43.26%71.67M-39.88%50.57M-46.93%50.6M-46.68%55.33M87.77%126.31M87.77%126.31M41.38%84.11M49.91%95.34M
Free cash flow 22.41%-20.47M52.34%-49.29M145.16%7.34M16.59%-14.96M26.57%-15.29M45.51%-26.38M-7.03%-103.42M44.11%-16.25M21.76%-17.93M-2.89%-20.83M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg